Nonpsychiatric medical costs high in bipolar disorder patients

By Mark Cowen, Senior medwireNews Reporter

The use of nonpsychiatric healthcare services is greater and associated costs higher in bipolar disorder (BD) patients than in those without the mood disorder, results from a Taiwanese study show.

Te Jen Lai (Chung Shan Medical University, Taichung) and colleagues found that 1-year total and nonpsychiatric medical costs were 11.7 and 1.7 times higher, respectively, in BD patients than in matched individuals without the disorder (controls).

The team also found that vasculometabolic diseases accounted for most of the increased use of nonpsychiatric medical services among patients with BD.

The findings come from a study of 4067 BD patients and 12,201 controls matched for age, gender, urbanization level, and income from the Taiwanese National Health Insurance inpatient and outpatient care claims database for the period 2006-2007.

The researchers found that the mean annual total medical cost for BD patients was NT$ 227,040 (US$ 7759, € 5989), which is significantly higher than the cost for controls, at NT$ 20,461 (US$ 699, € 539).

In addition, the mean annual nonpsychiatric medical cost was significantly higher for BD patients than controls, at NT$ 33,173 (US$ 1133, € 874) versus NT$ 19,406 (US$ 663, € 511).

The researchers also found that, compared with controls, BD patients had a significant higher prevalence of hypertension (rate ratio [RR]=1.90), diabetes (RR=3.19), hypertriglyceridemia (RR=2.25), heart disease (RR=1.55), cerebral vascular accident (RR=3.14), essential hypertension (RR=2.56), and lipid metabolism disorders (RR=2.28).

Furthermore, the cost for treating each of these comorbidities was significantly higher in BD patients compared with controls, "indicating that these conditions are more expensive to treat when comorbid with BD," says the team.

Lai and team conclude in the Journal of Affective Disorders: "The results of our study demonstrate that both the prevalence of vasculometabolic comorbidities and non-psychiatric healthcare utilization are higher in individuals with BD.

"Therefore, treatment of BD should integrate medical and psychiatric care to decrease the impact of medical comorbidities, which may also decrease overall medical costs."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers make strides in enhancing early diagnosis of bipolar disorder in adolescents